UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Altered EBV specific immune control in multiple sclerosis

Journal of neuroimmunology, 2024-05, Vol.390, p.578343-578343, Article 578343

Münz, Christian

2024

Volltextzugriff (PDF)

The Autophagic Machinery in Viral Exocytosis

Frontiers in microbiology, 2017-02, Vol.8, p.269-269

Münz, Christian

2017

Volltextzugriff (PDF)

Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications

Nature reviews. Neurology, 2023-03, Vol.19 (3), p.160

2023

Volltextzugriff (PDF)

Compartmentalization of Total and Virus-Specific Tissue-Resident Memory CD8+ T Cells in Human Lymphoid Organs

PLoS pathogens, 2016-08, Vol.12 (8), p.e1005799-e1005799

2016

Volltextzugriff (PDF)

Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells

PLoS pathogens, 2022-04, Vol.18 (4), p.e1010453-e1010453

2022

Volltextzugriff (PDF)

Evolution of functional antibodies following acute Epstein-Barr virus infection

PLoS pathogens, 2022-09, Vol.18 (9), p.e1010738-e1010738

2022

Volltextzugriff (PDF)

Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors

PLoS pathogens, 2021-12, Vol.17 (12), p.e1010137-e1010137

2021

Volltextzugriff (PDF)

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo

mBio, 2019-01, Vol.10 (1)

2019

Volltextzugriff (PDF)

Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection

PLoS pathogens, 2018-09, Vol.14 (9), p.e1007110-e1007110

2018

Volltextzugriff (PDF)

Role of human natural killer cells during Epstein-Barr virus infection

Critical reviews in immunology, 2014, Vol.34 (6), p.501

Münz, Christian

2014

Volltextzugriff (PDF)

A distinct subpopulation of human NK cells restricts B cell transformation by EBV

The Journal of immunology (1950), 2013-11, Vol.191 (10), p.4989-4995

2013

Volltextzugriff (PDF)

Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses

Viruses, 2021-05, Vol.13 (5), p.859

Münz, Christian

2021

Volltextzugriff (PDF)

Autophagy Proteins in Phagocyte Endocytosis and Exocytosis

Frontiers in immunology, 2017-09, Vol.8, p.1183-1183

Münz, Christian

2017

Volltextzugriff (PDF)

Natural Killer Cell Responses during Human γ-Herpesvirus Infections

Vaccines (Basel), 2021-06, Vol.9 (6), p.655

Münz, Christian

2021

Volltextzugriff (PDF)

Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components

Frontiers in immunology, 2018-02, Vol.9, p.238-238

Münz, Christian

2018

Volltextzugriff (PDF)

Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15

European journal of immunology, 2021-01, Vol.51 (1), p.64-75

2021

Volltextzugriff (PDF)

Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression

Cell host & microbe, 2017-07, Vol.22 (1), p.61-73.e7

2017

Volltextzugriff (PDF)

CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo

PLoS pathogens, 2019-05, Vol.15 (5), p.e1007748-e1007748

2019

Volltextzugriff (PDF)

The autophagy machinery interacts with EBV capsids during viral envelope release

Proceedings of the National Academy of Sciences - PNAS, 2023-08, Vol.120 (34), p.e2211281120-e2211281120

2023

Volltextzugriff (PDF)

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

Annals of neurology, 2010-02, Vol.67 (2), p.159-169

2010

Volltextzugriff (PDF)

Editorial: EBV-induced T cell immunity in cancers

Frontiers in immunology, 2024-07, Vol.15, p.1454792

2024

Volltextzugriff (PDF)

MHC class II‐deficient mice allow functional human CD4+ T‐cell development

European journal of immunology, 2023-07, Vol.53 (7), p.e2250313-n/a

2023

Volltextzugriff (PDF)

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells

The Journal of experimental medicine, 2017-06, Vol.214 (6), p.1827-1841

2017

Volltextzugriff (PDF)

Cognate HLA absence in trans diminishes human NK cell education

The Journal of clinical investigation, 2016-10, Vol.126 (10), p.3772-3782

2016

Volltextzugriff (PDF)

Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein–Barr Virus

Cancers, 2021-05, Vol.13 (9), p.2275

2021

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

ThemaTumors

ThemaEpstein-Barr Virus

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(63)
Buchkapitel
(2)

Sprache

Englisch
(65)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(48)
Humans
(42)
Immunology
(28)
Herpesvirus 4, Human - Immunology
(21)
Infections
(20)
Animals
(19)
Epstein-Barr Virus Infections - Immunology
(19)
Lymphoma
(16)
Mice
(14)
T Cells
(13)
Immune System
(12)
Proteins
(12)
Lymphocytes
(11)
Microbiology
(11)
Antigens
(10)
B-Lymphocytes - Virology
(10)
Lymphocytes T
(10)
Virology
(10)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Altered EBV specific immune control in multiple sclerosis

The Autophagic Machinery in Viral Exocytosis

Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications

Compartmentalization of Total and Virus-Specific Tissue-Resident Memory CD8+ T Cells in Human Lymphoid Organs

Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells

Evolution of functional antibodies following acute Epstein-Barr virus infection

Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo

Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection

Role of human natural killer cells during Epstein-Barr virus infection

A distinct subpopulation of human NK cells restricts B cell transformation by EBV

Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses

Autophagy Proteins in Phagocyte Endocytosis and Exocytosis

Natural Killer Cell Responses during Human γ-Herpesvirus Infections

Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components

Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15

Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression

CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo

The autophagy machinery interacts with EBV capsids during viral envelope release

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

Editorial: EBV-induced T cell immunity in cancers

MHC class II‐deficient mice allow functional human CD4+ T‐cell development

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells

Cognate HLA absence in trans diminishes human NK cell education

Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein–Barr Virus

Aktive Filter

Suchergebnisse filtern